Prognostic Model of Hernandez-Boluda et al for Survival After Allogeneic Hematopoietic Cell Transplantation of a Patient with Myelofibrosis (Spanish Risk Score)

Description

Hernandez-Boluda et al reported a prognostic model for a patient with myelofibrosis who undergoes an allogeneic hematopoietic cell transplant. The authors are from multiple institutions in Spain.

Patient selection: myelofibrosis

Parameters:

(1) HCT-CI (hematopoietic cell transplantation-specific comorbidity index)

(2) donor

(3) use of PT-Cy (post-transplant cyclophosphamide)

Parameter	Finding	Points
HCT-CI	< 3	0
	>= 3	1
donor	HLA-mismatched unrelated donor or cord blood	1
	other	0
use of PT-Cy	no	0
	yes	-1

total score =

= SUM(points for all of the parameters)

Interpretation:

• minimum score: -1

• maximum score: 2

Score	Risk Group	5-Year Overall Survival
-1	low	79%
0	intermediate	55%
1 or 2	high	32%

To read more or access our algorithms and calculators, please log in or register.

Prognostic Model of Hernandez-Boluda et al for Survival After Allogeneic Hematopoietic Cell Transplantation of a Patient with Myelofibrosis (Spanish Risk Score)

Description

Specialty